BRYAN, Texas, April 04, 2023 (GLOBE NEWSWIRE) -- iBio, Inc. (IBIO) (“iBio” or the “Company”), an AI-driven innovator of precision antibody immunotherapies, announced that a presentation given today by ...
DES PLAINES, Ill., Feb. 2, 2023 /PRNewswire/ -- Americaneagle.com, a family-owned, global digital agency, and ImmunoProfile, a medical diagnostics company, are proud to jointly announce the launch of ...
PHILADELPHIA, June 17, 2025 /PRNewswire/ -- Integral Molecular, the industry leader in discovering antibodies against membrane proteins, is pleased to announce that it has out-licensed a panel of ...
Multiplexed, multiparameter screening assays are foundational to the drug discovery process. By collecting more information, more rapidly – whether the focus antibodies, small molecules, or phenotypic ...
Existing monoclonal antibody development technologies, such as hybridoma technology, suffer from a loss of diversity due to cell fusion efficiency, and phage display technology creates antibodies ...
Advancement of therapeutic antibody discovery faces time and economic constraints. Merck R&D experts address this issue using Sphere Bio's microfluidic picodroplet technology. Fast, high-throughput ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback